Paul Kim has worked in Washington, DC for over 30 years. At Kendall Square Policy Strategies, Paul advises patient advocates, global life science leaders, and emerging companies on FDA and public health policy. He assists them in the development of legislative and policy strategies for regulatory reforms, drafting and enacting Federal legislation, and securing funding or creating effective P3s.

Paul's experience extends across drug and device law; rare disease innovation; public health and immunization policy; biodefense policy; and congressional oversight & investigations. Paul has represented leading biotechnology, pharmaceutical and medical device companies, trade associations, and patient advocacy groups before the US Food and Drug Administration (FDA), the Centers for Medicare and Medicaid Services (CMS), HHS ASPR/BARDA, and Congress.

Paul earned an undergraduate degree from Harvard University in History and Science and an M.P.P. in Science and Technology from the Harvard Kennedy School. He also holds a J.D. from Georgetown University.

‍